264 related articles for article (PubMed ID: 17697196)
1. Translational mini-review series on immunodeficiency: molecular defects in common variable immunodeficiency.
Bacchelli C; Buckridge S; Thrasher AJ; Gaspar HB
Clin Exp Immunol; 2007 Sep; 149(3):401-9. PubMed ID: 17697196
[TBL] [Abstract][Full Text] [Related]
2. Genetics of common variable immunodeficiency: role of transmembrane activator and calcium modulator and cyclophilin ligand interactor.
Sathkumara HD; De Silva NR; Handunnetti S; De Silva AD
Int J Immunogenet; 2015 Aug; 42(4):239-53. PubMed ID: 26096648
[TBL] [Abstract][Full Text] [Related]
3. Analysis of genetic defects in patients with the common variable immunodeficiency phenotype in a single Taiwanese tertiary care hospital.
Lee WI; Huang JL; Kuo ML; Lin SJ; Chen LC; Chen MT; Jaing TH
Ann Allergy Asthma Immunol; 2007 Nov; 99(5):433-42. PubMed ID: 18051214
[TBL] [Abstract][Full Text] [Related]
4. Three different classifications, B lymphocyte subpopulations, TNFRSF13B (TACI), TNFRSF13C (BAFF-R), TNFSF13 (APRIL) gene mutations, CTLA-4 and ICOS gene polymorphisms in Turkish patients with common variable immunodeficiency.
Kutukculer N; Gulez N; Karaca NE; Aksu G; Berdeli A
J Clin Immunol; 2012 Dec; 32(6):1165-79. PubMed ID: 22699762
[TBL] [Abstract][Full Text] [Related]
5. [Molecular basis of common variable immunodeficiency].
Neumann C; Grimbacher B
Dtsch Med Wochenschr; 2007 Apr; 132(16):885-7. PubMed ID: 17443446
[No Abstract] [Full Text] [Related]
6. TACI mutations and disease susceptibility in patients with common variable immunodeficiency.
Poodt AE; Driessen GJ; de Klein A; van Dongen JJ; van der Burg M; de Vries E
Clin Exp Immunol; 2009 Apr; 156(1):35-9. PubMed ID: 19210517
[TBL] [Abstract][Full Text] [Related]
7. Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.
Barbosa RR; Silva SL; Silva SP; Melo AC; Pereira-Santos MC; Barata JT; Hammarström L; Cascalho M; Sousa AE
J Clin Immunol; 2014 Jul; 34(5):573-83. PubMed ID: 24809296
[TBL] [Abstract][Full Text] [Related]
8. A novel compound heterozygous TACI mutation in an autosomal recessive common variable immunodeficiency (CVID) family.
Lougaris V; Gallizzi R; Vitali M; Baronio M; Salpietro A; Bergbreiter A; Salzer U; Badolato R; Plebani A
Hum Immunol; 2012 Aug; 73(8):836-9. PubMed ID: 22627058
[TBL] [Abstract][Full Text] [Related]
9. Transmembrane activator and calcium-modulator and cyclophilin ligand interactor mutations in common variable immunodeficiency.
Lee JJ; Ozcan E; Rauter I; Geha RS
Curr Opin Allergy Clin Immunol; 2008 Dec; 8(6):520-6. PubMed ID: 18978466
[TBL] [Abstract][Full Text] [Related]
10. Common variable immunodeficiency.
Takahashi N; Morio T
Nihon Rinsho Meneki Gakkai Kaishi; 2008 Feb; 31(1):9-16. PubMed ID: 18311038
[TBL] [Abstract][Full Text] [Related]
11. Novel mutations in TACI (TNFRSF13B) causing common variable immunodeficiency.
Mohammadi J; Liu C; Aghamohammadi A; Bergbreiter A; Du L; Lu J; Rezaei N; Amirzargar AA; Moin M; Salzer U; Pan-Hammarström Q; Hammarström L
J Clin Immunol; 2009 Nov; 29(6):777-85. PubMed ID: 19629655
[TBL] [Abstract][Full Text] [Related]
12. TACI mutation in common variable immunodeficiency and IgA deficiency.
Rachid R; Castigli E; Geha RS; Bonilla FA
Curr Allergy Asthma Rep; 2006 Sep; 6(5):357-62. PubMed ID: 16899196
[TBL] [Abstract][Full Text] [Related]
13. TACI mutations and impaired B-cell function in subjects with CVID and healthy heterozygotes.
Martinez-Gallo M; Radigan L; Almejún MB; Martínez-Pomar N; Matamoros N; Cunningham-Rundles C
J Allergy Clin Immunol; 2013 Feb; 131(2):468-76. PubMed ID: 23237420
[TBL] [Abstract][Full Text] [Related]
14. Transmembrane activator and calcium-modulating cyclophilin ligand interactor mutations in common variable immunodeficiency: clinical and immunologic outcomes in heterozygotes.
Zhang L; Radigan L; Salzer U; Behrens TW; Grimbacher B; Diaz G; Bussel J; Cunningham-Rundles C
J Allergy Clin Immunol; 2007 Nov; 120(5):1178-85. PubMed ID: 17983875
[TBL] [Abstract][Full Text] [Related]
15. TACItly changing tunes: farewell to a yin and yang of BAFF receptor and TACI in humoral immunity? New genetic defects in common variable immunodeficiency.
Salzer U; Grimbacher B
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):496-503. PubMed ID: 16264328
[TBL] [Abstract][Full Text] [Related]
16. Lymphocytes and B-cell abnormalities in patients with common variable immunodeficiency (CVID).
Berrón-Ruiz L; López-Herrera G; Vargas-Hernández A; Mogica-Martínez D; García-Latorre E; Blancas-Galicia L; Espinosa-Rosales FJ; Santos-Argumedo L
Allergol Immunopathol (Madr); 2014; 42(1):35-43. PubMed ID: 23305827
[TBL] [Abstract][Full Text] [Related]
17. Common variable immunodeficiency: an update on etiology and management.
Yong PF; Tarzi M; Chua I; Grimbacher B; Chee R
Immunol Allergy Clin North Am; 2008 May; 28(2):367-86, ix-x. PubMed ID: 18424338
[TBL] [Abstract][Full Text] [Related]
18. Effect of TACI signaling on humoral immunity and autoimmune diseases.
Zhang Y; Li J; Zhang YM; Zhang XM; Tao J
J Immunol Res; 2015; 2015():247426. PubMed ID: 25866827
[TBL] [Abstract][Full Text] [Related]
19. TACI, isotype switching, CVID and IgAD.
Castigli E; Geha RS
Immunol Res; 2007; 38(1-3):102-11. PubMed ID: 17917015
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of common variable immunodeficiency.
Castigli E; Geha RS
J Allergy Clin Immunol; 2006 Apr; 117(4):740-6; quiz 747. PubMed ID: 16630927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]